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When dobutamine, a synthetic adrenomimetic drug capable of stimulating a 1 -, b 1 -, and b 2 -adrenoceptors (18, 27, 29) , has been administered to subjects participating in bed-rest experiments, their exercise tolerance and aerobic capacity were significantly improved compared with results from controls receiving saline (32, 33) . Moreover, chronic infusions of dobutamine to animals were associated with improved myocardial O 2 consumption (V O 2 ) during submaximal exercise, significantly lower resting and exercise blood concentrations of lactic acid and catecholamines, as well as increased exercise tolerance (6, 14, 20) . Although Desplanches and co-workers (9) demonstrated in rats that dobutamine would prevent the decrease in maximum V O 2 (V O 2 max ) characteristic of simulated microgravity conditions (25) , their experimental design did not effectively address other performance aspects related to reduced run time (25, 34, 38) , decreased mechanical efficiency (25, 34, 38) , elevated concentrations of blood lactic acid and hydrogen ions (34) , or the increased rate of rise in colonic temperature regulation (34) . Consequently, to determine whether these aspects of exercise performance were improved and whether this adrenomimetic agonist deserved serious consideration as a potential countermeasure for future space missions, we conducted a simulated-microgravity study with rats receiving dobutamine.
METHODS
Experimental design. The duration of this experiment was 22 days. Before the study began, the rats were randomly assigned to groups designated as cage controls receiving saline (CC-S, n 5 8), head-down suspension receiving saline (HDS-S, n 5 6), or head-down suspension receiving dobutamine hydrochloride (HDS-D, n 5 8) that was generously provided by Eli Lilly (Indianapolis, IN). This design was selected to evaluate the effects of simulated microgravity, and the dosage of 1.8 mg/kg twice daily per rat was followed based on pilot studies and the findings of Desplanches et al. (9) , who had demonstrated that this concentration would not increase resting or the V O 2 max results of cage control animals; however, this dosage would restore the aerobic capacity of suspended rats. All testing was completed on day 21; 20 h later, the rats were anesthetized with pentobarbital sodium (50 mg/kg). Then select muscles of the hindlimbs were excised before the heart, lungs, kidney, spleen, and adrenal gland were removed, weighed, and heated in an oven at 100°C before determining their dry weight and water content.
Animal care. Permission for the study was received from the University of Arizona Animal Care and Use Committee. Male rats weighing between 275 and 325 g were then obtained from a commercial dealer (Harlan Sprague-Dawley, Indianapolis, IN) and assigned to individual cages located in a University-operated Central Animal Care Facility maintained at temperatures between 22 and 24°C with 12 h of lighting (6:00 AM to 6:00 PM) daily. The animals were fed daily a mash (1.85 kcal/g) (39) consisting of Wayne Rodent Blox, apple juice, ,60% water, parsnip extract, and cherry flavoring to promote eating. In addition, water and Wayne Rodent Blox were provided on an ad libitum basis. Before the start of the 22-day experimental period, the rats were ear tagged, weighed, and familiarized with treadmill running and with the procedure for measuring colonic temperatures. Finally, the rats were inspected daily by the authors and a veterinarian affiliated with the University of Arizona.
Suspension procedures. Microgravity conditions were simulated by using the tail-suspension method of Morey (22) that removes the hindlimbs from weight bearing and promotes a cephalic shift of fluids (34) . The rat tail was cleaned with 70% ethyl alcohol, allowed to dry, and sprayed with benzoin. Subsequently, an adhesive strip with a triangular metal clip was affixed to the upper third of the tail and adjusted in height to a suspended wire so that the rat's head was at an angle of ,45°to the floor of the cage. When the rats were tested in the treadmill on days 14 and 21, the tape and metal clip were removed for ,45 min before being resuspended.
Surgical procedures. Soon after they arrived, the animals were prepared for surgery. In brief, they were anesthetized with ketamine (0.1 ml/100 g) and instrumented with sterile polyethylene catheters (PE-50) in the left carotid artery and in the right vena cava. The catheters were positioned with 3-0 surgical silk, channeled subcutaneously to the neck of the animal, and exteriorized through a small incision in the skin. Then they were filled with sterile heparinized saline (10% heparin, 10% glucose) and heat sealed. After they recovered, the animals received 30,000 U of potassium penicillin G on two or three occasions and resumed their familiarization with treadmill running. When the animals returned to their presurgical body weight (,4.5 days), they were tested for peak V O 2 (V O 2 peak ) and the change in the heating index, then randomly assigned to an experimental group. One animal assigned to a suspension group died before the experiment began.
Exercise testing. All animals performed a progressive treadmill test that has been described previously (25) . Specifically, before the start of the study and on days 14 and 21, the rat rested for ,30 min in an airtight Plexiglas chamber that enclosed a motorized treadmill. The chamber had a constant airflow created by a vacuum pump and was connected to calibrated O 2 and CO 2 analyzers (Applied Electrochemistry, Ametek, Pittsburgh, PA) that were used to measure the content of expired air. Once resting values had been obtained, the animal performed a standardized exercise test that consisted of various 3-min stages. Stage 1 consisted of running at 13.4 m/min on 0°grade; stages 2-5 were 16.1 m/min at 5°, 21.4 m/min at 10°, 26.8 m/min at 10°, and 32.2 m/min at 12.5°, respectively. The testing continued until the animal was unwilling or unable to maintain a position in the middle of the treadmill. Expired values were recorded after 2 min of the exercise stage had been completed. For purposes of this study, V O 2 and CO 2 results are listed as peak values for STPD conditions, expressed on a mass basis, and were calculated by using computer programs that contained the gas-exchange equations published by Consolazio et al. (4) . On day 14, one rat in the HDS-S group was injured when he dove under the belt. Subsequently, he was killed, and his data were removed from the group for data analysis purposes.
When changes in colonic temperatures were obtained before and after a treadmill test (34) , a commercial thermistor (model 402, Yellow Springs Instruments, Yellow Springs, OH) was inserted 8 cm into the colon. Once equilibration was achieved, the temperature was recorded by using a Thermistemp recorder (model 42, Yellow Springs Instruments). These values, obtained when the animal was unrestrained on a table near the treadmill, were used to determine the heating index (rate of rise in colonic temperature in degrees Celsius per minute of run time). The animals were tested for V O 2 peak and the heating index before the study began and again 14 days later. On day 21, the rats performed a stage 2 treadmill test to determine changes in heart rate (HR), systolic blood pressures (SBP), and the double product (HR 3 SBP) (16) . These results were obtained at rest (while animals were suspended) and during exercise by connecting a precalibrated Statham pressure transducer (P23 DB, GouldStatham, Hato Rey, PR) connected to the catheter in the carotid artery and to a precalibrated Gilson recorder. After the stage 2 test was completed, the catheter connection to the transducer was removed and used to obtain arterial blood during maximal exercise. The testing conditions for maximal exercise were determined from day 14 V O 2 peak results.
To calculate the mechanical efficiency of running and its changes, stage 2 exercise testing results before the experiment and after 14 days of suspension were used for each rat. Specifically, the mass of the animal, the distance covered in 1 min, and the sine of the 5°treadmill angle were employed to calculate the kilogram-meters of work performed (3). The amount of O 2 consumed per minute during rest and exercise, and the respective respiratory exchange ratio values were used to determine the calories of energy expended. Gross and net mechanical efficiency were calculated by using the formulas listed by Brooks et al. (3) with the constant of 1 kg · m being equal to 2.343 calories (3) .
Resting colonic temperature and arterial constituents. Each day, starting at 8:00 AM, colonic temperatures were recorded from each rat in a standardized manner by using the same equipment and procedures described in the exercise-testing procedures to evaluate changes in the heating index. On day 21, when measurements of colonic temperature had been obtained and the animal had rested for 30 min (weightbearing or while suspended), two arterial blood samples (0.8 ml) were obtained and placed in an ice bath. Then donor blood was infused via the venous canula to replace the withdrawn volume before the animal was placed in an open treadmill. The findings from day 14 testing were then used to define the maximal testing conditions before the rat performed a stage 2 test for HR and BP measurements. Once the measurements were completed, the rat ran at its maximal capacity. After hematocrits were obtained, 0.8 ml of arterial blood was obtained under anaerobic conditions for determination of hemoglobin, pH, bicarbonate, and blood gases, and another 0.8 ml was secured for lactic acid concentration. The samples were then stored in ice until analyzed. Immediately after exercise, the colonic temperature of the rat was measured, and an equivalent amount of blood from a donor animal was infused into the rat before it was returned to its cage.
One blood sample was analyzed for hemoglobin, pH, arterial PO 2 (Pa O 2 ), arterial PCO 2 (Pa CO 2 ), and bicarbonate by using a previously calibrated automated blood-gas analyzer (model 1640, Instrumentation Laboratory) operated by certified research technicians in the Pulmonary Testing Laboratory of the University of Arizona Health Sciences Center. The colonic temperature of the rat was used to correct Pa O 2 and Pa CO 2 values by using an unpublished computer program developed by Dr. J. Dempsey of the University of Wisconsin at Madison. The second arterial sample was analyzed for lactic acid concentration by using procedures from Davies et al. (7) . In brief, the blood was instantly deproteinized with 1 ml of ice-cold perchloric acid (8% wt /vol), shaken on a Vortex, and then centrifuged before the supernatant was neutralized with KOH. Lactic acid concentration (in mM) was measured with calibrated solutions and a model 2700 biochemistry analyzer (Yellow Springs Instruments).
Data analyses.
Results were subjected to statistical analyses to determine means 6 SE. Analysis of variance for repeated measures was followed to determine intergroup and intragroup differences. When a significant F value was obtained, post hoc analyses were performed by using computer programs for Duncan's multiple-range test. The 0.05 probability level was selected to denote statistical significance of the findings. Table 1 are absolute mass changes, whereas Table 2 contains both absolute and relative (tissue or organ mass in mg or g/100 g body mass) results during the experimental period. As expected from relevant studies (25, 34, 36) , the CC-S rats exhibited a modest increase (2.4%) in mass during the study, whereas after 7 days, both suspended groups lost a significant amount of body mass (HDS-S, 27.5%; HDS-D, 28.0%) and did not return to their presuspension values before being killed (Table 1) . Suspension, either with saline or dobutamine injections, was associated with significant atrophy of ankle flexor muscles (soleus and plantaris; Table 2 ). Moreover, dobutamine was unable to prevent the atrophy of an ankle flexor muscle (extensor digitorum longus, Table 2 ). Suspension was associated with an increase in mass of the adrenal gland, whereas dobutamine and suspension were identified with an increase in the relative mass of the heart compared with the control animals ( Table 2 ). On the other hand, the experiment did not cause significant intergroup differences in the mass or the tissue-body mass ratio of the lungs, kidney, or spleen. In addition, calculations of percent water for these various structures revealed no intergroup differences that had statistical significance ( Table 2) .
RESULTS
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Resting and exercise colonic temperatures. The nonsignificant intergroup temperature data at day 0 in Table  3 indicated that the group assignment process was effective. However, after 7 days, the CC-S animals exhibited a modest increase (0.3°C), whereas the mean colonic temperature of the HDS-D rats was significantly decreased by 0.7°C. The reduction in temperature was apparent after 21 days because the HDS-D group had an intragroup F value that was statistically significant. Although there was a tendency for colonic temperatures in the CC-S group to decline after 14 days and for the temperatures in HDS-S group to be lower after 7 days, this trend had no statistical significance whether evaluated from an intra-or intergroup basis. On day 14 of the experimental period, and before maximal exercise, there were no results that indicated significant changes had occurred in resting values (Table 4) . While maximal exercise caused significant increases in colonic temperatures in each group before and during the experimental period, the intergroup differences had no statistical significance regardless of Values are means 6 SE in grams. CC-S, cage control and saline; HDS-S, head-down suspension and saline; HDS-D, head-down suspension and dobutamine. * Intragroup result was statistically significant at 0.05 level; † intergroup mean statistically significant at 0.05 level; ‡ significant difference between CC-S and HDS-S; § significant difference between CC-S and HDS-D; there were no significant differences between HDS-S and HDS-D. Table 4 ).
Aerobic performance and the rate of heating index. Figure 1 contains V O 2 peak findings that showed the HDS-S rats had significant decreases (213.5%) in contrast to the nonsignificant changes exhibited by the CC-S (23.1%) or by the HDS-D rats (20.6%). However, this restoration of aerobic performance by dobutamine was not evident in the run-time results of Fig. 2 . The HDS-S rats exhibited a significant decrease of 34.4%, whereas the HDS-D group had a significant reduction of 27.8%. Coupled with decreases in run times for the two HDS groups were significant increases in their rate of heating (Fig. 3) . Whereas the CC-S group had a nonsignificant elevation of 14.3%, both HDS groups had significant increases (87.5 and 58.3% for HDS-S and HDS-D animals, respectively). However, these differences had no statistical importance (F 5 0.64).
The intergroup F value of 5.00 was statistically significant at the 0.05 level. Table 5 demonstrates no significant intergroup differences in mechanical efficiency of running at a submaximal-intensity level (stage 2). Although the HDS-S animals exhibited a 30.6% reduction in this measure, this change was not statistically significant at the 0.05 level (F 5 3.79). On the other hand, the HDS-D rats demonstrated a reduction of 28.9%, which was statistically significant (F 5 13.28), whereas the CC-S had values that were similar to their baseline results (F 5 0.01).
Blood constituents before and during exercise. Maximal exercise caused significant increases in hydrogen ion concentrations in all groups, although the intergroup differences had no importance (F 5 1.58, Fig. 4) . Arterial values for lactic acid changes during exercise followed the same trend (Fig. 5) . Although the HDS-S group had values that were 27.4% higher and the HDS-D group means were 8% lower than the control animals, these differences had no statistical significance (F 5 1.46, Fig. 5 ). The blood gases and bicarbonate concentrations were evaluated before and during exercise, and there were no resting values that were Fig. 1 . Influences of head-down suspension (HDS) and dobutamine injections on peak O 2 consumption. Values are means 6 SE. CC-S, cage-control animals receiving saline; HDS-S, tail-suspended rats receiving saline; HDS-D, tail-suspended rats receiving dobutamine. Differences noted between HDS-S and other 2 groups after suspension were statistically significant. significantly different from the control animals (Table  6 ). When maximal exercise was performed, the intensity was sufficiently strenuous to cause all groups to demonstrate significant increases in Pa O 2 , decreases in Pa CO 2 , and reductions in bicarbonate concentration (Table 6 ). The hematocrit data in Table 6 showed the HDS-S rats had marked reductions after exercise, which caused the intergroup F value to be statistically significant (F 5 5.25). This finding was unexpected and difficult to explain. However, the HDS-D rats had values similar to the cage controls. When hemoglobin was assessed, there were no significant intergroup differences, although the HDS-S animals had lower values than the other two groups (Table 6) .
Insights on the effects of suspension, dobutamine, and submaximal exercise on hemodynamic and myocardial responses are summarized in Table 7 . Compared with control values measured at rest, suspension coupled with either saline or dobutamine injections was associated with increased HR by 17.5 and 11.0% for HDS-S and HDS-D, respectively, which was significant for the HDS-S animals. With submaximal exercise, all groups experienced significant intragroup increases, and the HDS-S intergroup differences noted were statistically significant. SBP measurements at rest and during exercise showed no intergroup differences that had statistical significance. Interestingly, only the CC-S rats had arterial pressures during submaximal exercise that were statistically significant (F 5 8.30). At rest, the double product for the two HDS groups was significantly higher than for the control animals (Table  7) , whereas during exercise the intergroup F value was 0.81, even though the HDS-D rats had a product that was 10% higher than the CC-S group.
DISCUSSION
Before evaluating the significance of these results from an animal model for simulated conditions of microgravity, it is important to realize that, despite the numerous physiological changes that are associated with spaceflight (24) , maximal exercise in space, as evaluated by V O 2 max tests with astronauts, is not significantly changed (19) . Consequently, a major issue facing National Aeronautics and Space Administration is whether returning astronauts have the physiological ability to perform sustained maximal exercise after scheduled or unscheduled landings. Data collected after actual (19) or simulated conditions for microgravity (5, 28, 32, 34, 38, 39) suggest they would experience marked difficulty.
Sufficient evidence from animal and human investigations has demonstrated that maximal exercise requires the activation and participation of the sympathetic nervous system (26) . However, the inflight changes in this component of the autonomic nervous system are unclear. To date, no direct recordings of sympathetic nerve activity (microneurography) have been done, and inflight measurements of catecholamines have shown both increases and decreases with brief duration missions and increases with much longer ones (34) . But urinary data collected on the day of landing of Mir cosmonauts who had been in space for 1 yr showed decreases in norepinephrine (NE) and increases in epinephrine (Epi; Ref. 15) . One day later, the plasma concentrations of both NE and Epi were elevated above preflight values. In a 9-day head-down-tilt experiment, plasma concentrations of both catecholamines were reduced (12) , whereas in a 120-day study, plasma Epi was elevated whereas NE was decreased compared with baseline values (8) . Of relevance are the reports that animals flown in space for 6.5 days had a reduction in the number of myocardial b-receptors compared with their controls (17) , and that suspended rats had significantly higher resting plasma concentrations of catecholamines (NE for 14 days, Epi for 7 days) than their caged controls (39) . Our results with exercising rats after suspension (75% V O 2 max ), compared with their caged controls, not only exhibited significant decreases in cardiac output, stroke volume, and blood flow to leg muscles (37) but showed that the estimated sympathetic nerve traffic (rate of NE depletion) to the myocardium was 82% lower and to the soleus muscle was 47% higher (36) . Hence, we concluded that simulated microgravity reduced exercise performance by an inability to augment cardiac output or to effectively redistribute blood flow because of an altered sympathetic nervous system. It is known that dobutamine acts directly on b 1 -adrenoceptors in the heart and enhances myocardial contractility (6, 18) . Thus the normalization of the V O 2 peak results in Fig. 1 was likely a result of an elevated cardiac output caused by an improved stroke volume. Similar findings were noted for post-bed-rest subjects performing an exercise test after receiving injections of dobutamine (33). Besides improving stroke volume and O 2 delivery, dobutamine has been associated with increased arteriovenous O 2 differences (33) and retention of plasma volume (33). Therefore, the normalization of the pH and lactic acid data summarized in Figs. 5 and 6 could be explained, in part, by these effects. Limited human data from cosmonauts (21), postflight animal results (1, 34, 35) , and findings from bed-rest studies (5, 28) suggest that microgravity favors the utilization of carbohydrates by skeletal http://jap.physiology.org/ muscles and decreases the utilization of free fatty acids. Thus, value of dobutamine as a potential countermeasure is enhanced by these collective results.
On the other hand, suspension caused significant reductions in treadmill run time, and the repeated injections of dobutamine demonstrated no significant group effect (Fig. 2) . In fact, mature or old (34), chemically sympathectomized (36, 38) , or hypophysectomized rats (34) that have been previously suspended also exhibit significant reductions in this measure. Many years ago, Donovan and Brooks (10) concluded from their rat metabolic studies that tests for V O 2 max and endurance running were evaluating different physiological mechanisms. Although the results support their statement and indicate that exogenous stimulation of adrenoceptors had no apparent benefit, our findings do not delineate the reasons why.
Dobutamine administration was also unable to prevent the decrease in the mechanical efficiency of running that is associated with suspension (Table 5) . Similar trends have been reported in normal, shamoperated, hypophysectomized, or chemically sympathectomized rats, although with these animals (34, 39) , an apparent mechanical efficiency value was calculated (2). We decided not to present the mechanical efficiency data in this manner, because this regression method requires more data points and because we were interested in comparing the absolute changes that occurred during stage 2 exercise (16.1 m/min at 5°grade). Why mechanical efficiency decreases with conditions of simulated microgravity is not clear. We repeatedly observe that rats after suspension will run with an altered gait which suggests that a change in central command has occurred because of different sensory stimuli. This situation could result in a recruitment of different muscle groups, which could explain both the gait changes and the decrease in mechanical efficiency.
The decreases in body and muscle mass (Tables 1 and  2 ) could also contribute to the decrease in treadmill run time (Fig. 2) and to the decline in mechanical efficiency (Table 5 ). However, it was apparent that dobutamine administration was unable to prevent the decline in mass that is characteristic of male animals exposed to conditions of simulated microgravity (34) . Moreover, inspection of Table 2 for antigravity muscle differences showed the HDS-D rats had values for the soleus and plantaris muscles that were similar to those of the HDS-S rats. The soleus results confirmed the findings of Desplanches et al. (9) , who demonstrated that significant decreases (,60%) had occurred after 35 days of suspension. On the other hand, the decrease in body mass reported by Desplanches et al. was not statistically significant for their younger female rats. Because clembuterol injections in rats (an adrenomimetic b 2 -receptor agonist) can increase body and hindlimb muscle mass, as well as muscle functional characteristics (11), differences in b 2 -receptor properties may explain our negative results and those reported by Desplanches et al. (9) . Although Sullivan et al. (33) attributed an increase in aerobic enzyme activity to the actions of dobutamine, this trend was not present in the muscle data published by Desplanches and associates (9) .
Numerous reports from space suggest that astronauts and cosmonauts experience problems in their ability to regulate body temperature (13, 34) . When temperature regulation experiments have been conducted with subjects confined to bed for 14 days, the submaximal exercise data indicated the bed-rested subjects had significantly higher rectal temperatures than their controls (13) . Because the temperatureregulating system is intimately associated with the functions of the sympathetic nervous system, we speculated that dobutamine would help maintain resting colonic temperatures and enhance vasodilation mechanisms during exercise. The resting-temperature data in Table 3 indicated that this postulate was not confirmed, as the HDS-D animals exhibited a decline in colonic temperature that was statistically significant at the 0.05 level. Unexpectedly, the data in Table 4 indicated the HDS-S rats did not demonstrate a reduction in colonic temperature, as reported by Shellock et al. (30) and by our laboratory (34) . Although we cannot state why these specific rats did not exhibit a significant decline in their mean colonic temperature, we can state that daily injections of dobutamine were unable to prevent a reduction. Because dobutamine increases cardiac output and stroke volume, prevents a fall in plasma volume (32) , and acts on b 2 -adrenoceptors (29), we expected that it would influence the rate of heating index (change in colonic temperature/min) for the HDS-D rats after exercise. As shown in Fig. 3 , both groups of HDS animals had significant increases in this index, suggesting that their ability to dissipate a rapidly increasing heat load had been impaired. This is an interesting and unexpected finding and may be related, in part, to both groups having significantly shorter run times. The pre-and postexercise colonic temperatures in Table 4 indicate that the treadmill test was sufficiently strenuous to significantly elevate these measures. However, colonic temperatures from the various groups were not sufficiently different to explain their heating index values. As in previous experiments (34), HDS-S rats exhibited trends for higher postexercise values than did their salineinjected controls. However, these differences had no statistical significance. Animals receiving dobutamine had pre-and postexercise values that were similar to the other two groups.
A study of head-down humans in Russia (31) showed that Pa O 2 values had become significantly decreased with time, presumably because of an increase in pulmonary edema. Because our short-term studies with rats had suggested that lungs had become heavier with suspension (34), we secured blood-gas measurements before (while tilted) and during exercise. However, there were no Pa O 2 values (Table 6 ) or lung wet and dry weight results ( Table 2 ) that indicated 14 to 21 days of suspension had a significant influence on these parameters. The other blood data in Table 6 demonstrated that the exercise performed produced significant changes, but none of the intergroup differences, except 1613 DOBUTAMINE AND SIMULATED MICROGRAVITY by 10.220.32.246 on July 11, 2017 http://jap.physiology.org/ hematocrit, had statistical importance or dramatized the value of dobutamine as a countermeasure. Frankly, it is unclear why the hematocrit measure with the HDS-S animals was significantly different after exercise (Table 6 ). We do know that suspension is associated with significant reductions in plasma and red blood cell volumes (25, 34) , and this relationship could explain the resting value. However, because exercise is associated with hemoconcentration rather than hemodilution, we must refrain from placing biological significance on the intergroup F value shown in Table 6 .
Dobutamine is known to increase myocardial function and V O 2 (14, 20) ; hence, we collected submaximal exercise data and calculated the double product to indirectly assess the changes in myocardial V O 2 and cardiac contractility (16) . The intergroup exercise data in Table 7 for stage 2 submaximal exercise shows, compared with control animals, that the HDS-D rats had higher values for HR (11%) and a lower (4%) SBP. The net effect for estimated myocardial O 2 consumption was an increase. It is possible that the HDS-D rats had a slightly higher stroke volume that enabled them to achieve a higher V O 2 in a shorter period of time than the CC-S rats. If correct, the kinetics of V O 2 with dobutamine should be investigated in greater detail.
In summary, we used an animal model for simulated microgravity to investigate the value of dobutamine as a potential countermeasure for post-spaceflight decrease in exercise performance. We confirmed that V O 2 peak was retained and demonstrated that lactic acid concentrations during maximal exercise exhibited a trend toward normalization by the dobutamine treatment. However, this adrenomimetic agonist was ineffective in restoring treadmill run time, reducing the rate of rise of colonic temperature after exercise, or preventing the decrease in the mechanical efficiency of running. In addition, dobutamine was unable to prevent the decline in the mass of the body or of select ankle flexors. Finally, resting colonic temperature was significantly decreased with 14 days of suspension. The impression from these collective results is that the value of dobutamine as a countermeasure for postspaceflight exercise performance is limited to select aerobic mechanisms and that other approaches and compounds will be needed for future spaceflights.
